Your institution may have access to this item. Find your institution then sign in to continue.
Title
Briefs.
Abstract
The article presents new briefs on the biotechnology industries as of 2006. Evotec Technologies was acquired by PerkinElmer in a deal worth $30.5 million. The deal for the acquisition of Inpharmatica in Great Britain by Galapagos in Belgium is expected to be completed in March 2007. Andrew von Eschenbach was confirmed as the U.S. Food and Drug Administration's commissioner.